A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration
about
From animal models to human disease: a genetic approach for personalized medicine in ALSClinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V).ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity.Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions.
P2860
A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A truncating SOD1 mutation, p. ...... ntotemporal lobar degeneration
@en
A truncating SOD1 mutation, p. ...... totemporal lobar degeneration.
@nl
type
label
A truncating SOD1 mutation, p. ...... ntotemporal lobar degeneration
@en
A truncating SOD1 mutation, p. ...... totemporal lobar degeneration.
@nl
prefLabel
A truncating SOD1 mutation, p. ...... ntotemporal lobar degeneration
@en
A truncating SOD1 mutation, p. ...... totemporal lobar degeneration.
@nl
P2093
P2860
P1476
A truncating SOD1 mutation, p. ...... ntotemporal lobar degeneration
@en
P2093
Dennis W Dickson
Janice Robertson
Kevin B Boylan
Masataka Nakamura
Matthew C Baker
Monica Castanedes-Casey
Neill R Graff-Radford
Nicola J Rutherford
Pamela Desaro
Rosa Rademakers
P2860
P2888
P304
P356
10.1007/S00401-015-1431-2
P577
2015-04-28T00:00:00Z